Mucormycosis in ICU

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

September 10, 2017

Study Completion Date

June 1, 2018

Conditions
Mucormycosis
Trial Locations (21)

Unknown

Intensive Care Unit - Hospital Amiens, Amiens

Intensive Care Unit - Hospital Angers, Angers

Intensive Care Unit - Hospital Besançon, Besançon

Intensive Care Unit - Hospital Béthune, Béthune

Intensive Care Unit - Hospital Caen, Caen

Intensive Care Unit - Hospital Clermont-Ferrand, Clermont-Ferrand

Intensive Care Unit - Hospital Dijon, Dijon

Intensive Care Unit - Hospital Grenoble Alpes, Grenoble

Intensive Care Unit - Hospital Lille, Lille

Intensive Care Unit - Hospital Lyon, Lyon

Intensive Care Unit - Hospital Montpellier, Montpellier

Intensive Care Unit - Hospital Nantes, Nantes

Intensive Care Unit - Hospital l'Archet - Nice, Nice

Intensive Care Unit - Hospital Bichat, Paris

Intensive Care Unit - Hospital Saint Louis, Paris

Intensive Care Unit - Hospital Tenon, Paris

Intensive Care Unit - Hospital Poitiers, Poitiers

Intensive Care Unit - Hospital Rennes, Rennes

Intensive Care Unit - Hospital Rouen, Rouen

Intensive Care Unit - Hospital Saint Etienne, Saint-Etienne

Intensive Care Unit - Hospital Tours, Tours

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT03387696 - Mucormycosis in ICU | Biotech Hunter | Biotech Hunter